Women's Health Issues
Volume 14, Issue 1 , Pages 7-10, January 2004

The Letrozole Breast Cancer Trial: clinical implications and remaining questions

  • Wendy Y. Chen, MD, MPH

      Affiliations

    • Channing Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA
    • Division of Medical Oncology, Dana Farber Cancer Institute, Harvard Medical, Boston, Massachusetts, USA
    • Corresponding Author InformationCorrespondence to: Wendy Y. Chen, MD MPH, Channing Laboratory, third floor, 181 Longwood Avenue, Boston, MA 02115, USA.
    • ,
  • JoAnn E. Manson, MD, DrPH

      Affiliations

    • Division of Preventive Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA

Received 12 December 2003

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1049-3867(03)00119-1

doi:10.1016/j.whi.2003.12.006

Women's Health Issues
Volume 14, Issue 1 , Pages 7-10, January 2004

Article Tools